Having trouble accessing articles? Reset your cache.

GTx-758: Phase II data

An open-label Phase II trial in 60 healthy male volunteers showed that 1,000 and 1,500 mg/day oral

Read the full 172 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE